In models of pulmonary fibrosis and silicosis treatment, targeting the PI3K/AKT signaling pathway inhibits pulmonary fibroblast proliferation and migration while promoting apoptosis, thereby alleviating silica-induced pulmonary fibrosis. Here, PIK3CA is linked to pulmonary fibrosis.